Completed OBSERVATIONAL NCT02171182

A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

A Non-interventional Post-registration Clinical Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

Sponsor: Astellas Pharma s.r.o.

Conditions Post-operative Peripheral Neuropathic Pain

Interventions Qutenza

Updated 8 times since 2017 Last updated: Feb 5, 2016 Started: Jan 31, 2014 Primary completion: Aug 31, 2015 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Post-operative Peripheral Neuropathic Pain, this trial is completed. The trial is conducted by Astellas Pharma s.r.o. and has accumulated 8 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Astellas Pharma s.r.o.

Data source: Astellas Pharma Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Benešov, Czechia , Beroun, Czechia , Brno, Czechia , Havlíčkův Brod, Czechia , Hořovice, Czechia , Hradec Králové, Czechia , Jihlava, Czechia , Karlovy Vary, Czechia , Klatovy, Czechia , Krnov, Czechia and 15 more locations